A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Commerce119-s4066 — A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.. Sponsored by Sen. Hawley, Josh [R-MO]. Introduced 2026-03-11. Senate bill. 119th Congress. Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsor
- Sen. Hawley, Josh [R-MO] (R), MO
- Introduced
- 2026-03-11
- Committees
- Health, Education, Labor, and Pensions Committee
- Latest Action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
No roll-call vote data available for this bill.
Similar Bills
- 117-s797 — PACT Act 42% match 117th Congress
- 118-s483 — Internet PACT Act 33% match 118th Congress
- 118-s1876 — Platform Accountability and Transparency Act 27% match 118th Congress
- 117-s3608 — Social Media NUDGE Act 22% match 117th Congress
- 119-hr2149 — Correcting Guamâs History in the PACT Act 22% match
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis